China SXT Pharmaceuticals, Inc.

For the period ended Sep 30, 2024. Filed Mar 28, 2025.

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Sep 30, 2024 · Filed Mar 28, 2025

Use the contents to explore the available documents and sections.

SXTC$2.83-3.4%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

Explanatory Note

China SXT Pharmaceuticals, Inc. (the “Company”) is furnishing this Form 6-K to provide its financial results for the six months ended September 30, 2024.

The Company hereby furnishes the following documents as the exhibits to this report: “Unaudited Condensed Consolidated Financial Statements for the six months ended September 30, 2024 and 2023” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.